Quarterly report
Open the filing on sec.gov
Advanced Biomed Inc. (ADVB)
Nasdaq: ADVB · Services-Medical Laboratories · Reno, NV · filing with the SEC since 2022
The companyfiscal 2026, as filed
Revenue$127,637
Net income$6.7M+304.9%
Earnings per share$5.33+267.6%
Operating cash flow-$1.9M+66.6%
Cash$385,535+1138.1%
Debtn/a
Shareholders’ equity$12.3M+253.0%
Shares, diluted1,252,727+22.1%
Return on equity54.4%
The recordfrom its filings
Filings in 202626
Newest filingNov 12 · 10-Q
Annual reportOct 13, 2026
Quarterly reportNov 12, 2026
Next report due10-Q by Feb 14
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Trailing twelve months to Sep 2026Net income $6.1MCash from operations -$1.5Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Annual report
Open the filing on sec.gov
Late annual report notice
Open the filing on sec.gov
Large holder notice
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Large holder notice
Open the filing on sec.gov
Registration withdrawal request
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.